Form 4: PDS Biotechnology Director Otis W. Brawley Acquires 9,000 Stock Options
SEC Form 4 Filing
Director Otis W. Brawley acquired 9,000 employee stock options in PDS Biotechnology Corp on June 24, 2024.
Summary
- On June 24, 2024, Otis W. Brawley, a director of PDS Biotechnology Corp, acquired 9,000 employee stock options.
- The exercise price of these options is $2.86.
- The options vest fully on the first anniversary of the grant date, contingent upon Brawley's continued service as a director.
- The options expire on June 24, 2034.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine transaction. The granting of options to a director is generally seen as a positive sign, but it's not a major event.
Positives
- The acquisition of stock options by a director signals confidence in the company's future performance.
Industry Context
This is a standard SEC Form 4 filing, indicating a change in beneficial ownership of securities by a company insider. It is common for directors and officers to receive stock options as part of their compensation.
Stakeholder Impact
- The granting of stock options to a director can align their interests with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/24/2024 | Date of transaction: Otis W. Brawley acquired 9,000 employee stock options. |
| 06/24/2025 | Vesting date: Stock options vest fully, subject to continued service as a director. |
| 06/24/2034 | Expiration date: Stock options expire. |
| 06/25/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.